Comparative Efficacy and Safety of Individual SGLT2 Inhibitors (Dapagliflozin, Empagliflozin, and Canagliflozin) on Kidney Function Decline in CKD: A Systematic Review and Network Meta-Analysis. OAIJMR. 2025;5(6):1772-1789. doi:10.37275/oaijmr.v5i6.818